Oric Pharmaceuticals, Inc.·4

Apr 28, 5:11 PM ET

Topspin Fund L.P. 4

4 · Oric Pharmaceuticals, Inc. · Filed Apr 28, 2020

Insider Transaction Report

Form 4
Period: 2020-04-28
Transactions
  • Conversion

    Common Stock

    [F1][F2]
    2020-04-28+231,250231,250 total
  • Conversion

    Common Stock

    [F1][F2]
    2020-04-28+497,809729,059 total
  • Conversion

    Common Stock

    [F1][F2]
    2020-04-28+314,8151,043,874 total
  • Conversion

    Common Stock

    [F1][F3]
    2020-04-28+2,268,7502,268,750 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    [F1][F2]
    2020-04-28231,2500 total
    Common Stock (231,250 underlying)
  • Conversion

    Series C Preferred Stock

    [F1][F2]
    2020-04-28497,8090 total
    Common Stock (497,809 underlying)
  • Conversion

    Series D Preferred Stock

    [F1][F2]
    2020-04-28314,8150 total
    Common Stock (314,815 underlying)
  • Conversion

    Series B Preferred Stock

    [F1][F3]
    2020-04-282,268,7500 total(indirect: See footnote)
    Common Stock (2,268,750 underlying)
Footnotes (3)
  • [F1]Each of the Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock automatically converted into shares of Common Stock on a one to one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock for no additional consideration and has no expiration date.
  • [F2]The shares are held of record by Topspin Fund, L.P. LG Management, LLC, the general partner of Topspin Fund, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.
  • [F3]The shares are held of record by Topspin Biotech Fund II, L.P. LG Management, LLC, the general partner of Topspin Biotech Fund II, L.P., may be deemed to have voting and dispositive power with respect to the shares. Leo A. Guthart, the managing member of LG Management, LLC, may also be deemed to have voting and dispositive power with respect to the shares. Each of LG Management, LLC and Leo A. Guthart disclaims beneficial ownership of the shares, except to the extent of their respective indirect pecuniary interests in such shares.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION